Term
|
Definition
Major factor in determining success of chemotherapy |
|
|
Term
|
Definition
1. Dactinomycin
2. the -rubicins
3. mechlorethamine (mustargen)
4. Vincristine |
|
|
Term
|
Definition
* Can cause extravasation
* Know emergency treatment before giving vesicants IV
Long -Term Consequences
* Possible infertility
* IRF secondary tumors |
|
|
Term
|
Definition
1. Cyclophosphamide (Cytoxan)
2. Mechlorethamine (Mustargen)
3. Cisplatin (Platinol)
4. Carboplatin (paraplatin) |
|
|
Term
Side Effects of Alykylating Agents
|
|
Definition
1. Bone Marrow Suppression
2. Hemorrhagic cystitis
3. Ototxic - will never recover
4. Pulmonary toxicity - need to discontinue drugs - will look like copd
5. Neurotoxic - peripheral neuropathy, pain |
|
|
Term
|
Definition
1. Methotrexate (Folex, Mexate)
2. Gemcitabine (Gemzar)
3. -bine
4. Fluoruracil (5FU) |
|
|
Term
Side Effects of Antimetabolites |
|
Definition
1. Bone Marrow Toxicity
2. Hepatotoxic - liver failure is normal reason these drugs are discontinued)
3. Pregnancy Category X - must avoid pregnancy for 6 mo following last dose
4. Photosensitivity |
|
|
Term
|
Definition
1. Doxorubicin (Adriamycin)
2. - rubicin
3. Bleomycin (Blenoxane) |
|
|
Term
Side Effects of Antitumor Antibiotics |
|
Definition
1. Cardiotoxic (irreversible HF)
2. Decreases Digoxin levels |
|
|
Term
Hormone/Hormone Antagonist |
|
Definition
1. Tamoxifen (Nolvadex)
2. Steroids
|
|
|
Term
Adverse Effects of Hormones/Hormone Antagonists |
|
Definition
Note: It's all about estrogen (they look like they are going through menopause)
Nausea/Vomiting
IRF endometrial cancer
thromboemolitic disease
IRF blood clots
Hot flashes, fluid retention, vaginal discharge |
|
|
Term
|
Definition
1. Vincristine (Oncovin)
2. Docetazel (Taxotere)
3. Paclitaxel (Taxol)
4. Etoposide (VePesid) |
|
|
Term
Side Effects of Natural Products |
|
Definition
1. Nervous system toxicity (numbness and tingling in limbs)
a. muscular weakness, loss of reflexes
b. paralytic ileus, constipation
2. Cardiotoxic
3. Acute bronchospasm: must be at bedside for first few administrations
4. Suicide ideation
5. Nephrotoxicity |
|
|
Term
Biologic Response Modifiers |
|
Definition
Stimulate or assist client's immune system to rid itself of cancer cells
Less toxic
Interferons, interleukins, monoclonal antibodies |
|
|
Term
|
Definition
1. Sub Q administration 3X/week
2. Slow and controlled elevation of RBC (Max Hgb 36%)
3. Dangerous spike in BP - hard to treat; B-Blocker doesn't automatically help
4. Thrombolytic events |
|
|
Term
Filgastrim (Neupogen, G-CSF) and Pegfilgastim (Neulasta) |
|
Definition
Accelerate neutrophil production and activation
Sub Q injection
Filgastim = HTN, St depression/MI, bone pain before neutrophils inrease
Start 24 hrs after chemo |
|
|
Term
Sargramostim (GM - CSF) (Leukine)
|
|
Definition
Granulocyte and Macrophage stimulation
IV administation and infused over 2 hrs
Respiratory Distress during administration *Restlessness
* Dyspnea
* Tachycardia
Supraventricular Tachycardia
Use with caution with HF |
|
|
Term
Oprelvekin (Neumega)Stimulates the production of megakaryocytes aand thrombopoietin (precursors to platelets) |
|
Definition
1. Sub Q injection once daily 24 hrs after chemo
2. Takes 5 - 10 days for effects
3. Watch fluid retention
4. Withhold: 12 hrs b/f and after radiation therapy |
|
|